A look inside HBRF’s October 11th, 2023 Luncheon Event How hopeful do you feel about the future of biotechnology accessibility in the United States? If you joined Hope Biosciences Research Foundation (HBRF) on Wednesday, October 11th for our “Hope is Here” event, we hope that your answer is “very!” Held…

Real information to support real healthcare decisions Most digital visitors to Hope Biosciences Research Foundation (HBRF) arrive by very personal motivation — either they or a loved one are likely living with a degenerative disease or illness without palatable or effective treatment options. Digital seekers of information often report being…

A people-centered look at a little-known consideration As June winds to a close and with it, PTSD Awareness Month, now seems an opportune time to leave as a parting “awareness month” thought the presence of PTSD in the clinical research landscape outside of mental health-specific studies, like are conducted at…

Assessing “quality of life” in clinical research Think back on the resolutions you made at the beginning of the new year, the goals you set, the dreams and desires whispered from your heart. Odds are high that if you established objectives as the calendar year flipped at least one of…

An intro to allogeneic cell therapy and why it matters Hope Biosciences Research Foundation (HBRF) conducts sometimes simultaneous research in the same disease or injury condition, exploring both autologous cell therapy (using a patient’s own stem cells) and allogeneic therapy (using carefully selected donor cells). At the time of this…

The story of “Mission Control” at Hope Biosciences Research Foundation Walk into Hope Biosciences Research Foundation and you will notice a new sign gracing the wall these days, eye level by the door to the large room where the entire Hope team works. “Paxton Bernal Mission Control Room,” it reads…

Bottom line, up front: in 2022, Hope Biosciences Research Foundation (HBRF) began or continued work in seven FDA-authorized protocols, including in COVID-19 and “Long Haul” COVID, multiple sclerosis, and Parkinson’s disease; six are Phase II clinical trials. HBRF also executed 24 FDA-authorized expanded access protocols in Chronic Idiopathic Demyelinating Polyneuropathy…

Ever heard of someone throwing you a party to celebrate THEIR birthday? Well, that’s exactly what Gibco, a prominent cell culture brand available through Thermo Fisher Scientific, has been doing at locations around the world to celebrate their 60th anniversary and 60 years of loving cell culture! I guess they…

Translating laboratory discovery into patient care — The phrase “bench to bedside” describes the process by which the results of research done in the lab are directly used to develop new ways to treat patients. This is exactly what we do at Hope Biosciences with our adipose-derived mesenchymal stem cell product, HB-adMSCs. Our mission in the lab…